In liver

Vitamin B,2 is produced by the growth of certain micro-organisms, and occurs also in liver, being the extrinsic anti-pernicious anaemia factor the isolation of which was sought for many years. 

Sotalol is rapidly and almost completely (>90%) absorbed. Bioavahabhity of absorbed dmg is 89—100%. Peak plasma levels are achieved in 2—4 h. Sotalol is 50% bound to plasma proteins. Plasma half-life of the compound is about 5.2 h. No metabolites of sotalol have been identified indicating littie metabolism. The dmg is excreted mainly by the kidneys (80—90%) and about 10% is eliminated in the feces. The plasma half-life is prolonged in patients having renal failure. Kinetics of the compound are not affected by changes in liver function (1,2). Sotalol has ah the adverse effects of -adrenoceptor blockers including myocardial depression, bradycardia, transient hypotension, and proarrhythmic effects (1,2). 

Oxyphenbutazone (712), y-hydroxyphenylbutazone and kebuzone (715) are metabolites of phenylbutazone in liver. The first cited is an equally potent antiinflammatory agent but slightly less toxic. Compounds (711) and (712) are rarely used as analgesics and antipyretics because of their toxicities. The first one is used in therapy of rheumatoid disorders characterized by a lack of detectable antiglobulin and antinuclear antibodies in the serum. The y-hydroxyphenylbutazone has marked uricosuric activity but little antirheumatic effect. Kebuzone (715) is an antiinflammatory agent still widely used in Europe. 

The specimens analyzed are the punctures of human liver. This provides the life-time investigation of elemental metabolism in liver of patient. This is very important aspect, because the information obtained from autopsy is distorted because of fast processes in the liver post mortem. 

Insulin is a peptide hormone, secreted by the pancreas, that regulates glucose metabolism in the body. Insufficient production of insulin or failure of insulin to stimulate target sites in liver, muscle, and adipose tissue leads to the serious metabolic disorder known as diabetes mellitus. Diabetes afflicts millions of people worldwide. Diabetic individuals typically exhibit high levels of glucose in the blood, but insulin injection therapy allows diabetic individuals to maintain normal levels of blood glucose. 

FIGURE 24.28 The formation of ketone bodies, synthesized primarily in liver mitochondria. 

Even though acetate units, such as those obtained from fatty acid oxidation, cannot be used for net synthesis of carbohydrate in animals, labeled carbon from " C-labeled acetate can be found in newly synthesized glucose (for example, in liver glycogen) in animal tracer studies. Explain how this can be. Which carbons of glucose would you expect to be the first to be labeled by "Relabeled acetate ... 

AlOiOHl bep 0 lOHl wiib chains of oclahedra sl-a ked in livers inlerconneUed wiib H bonds. sid Al in cerkiii ockibcdral sites... 

Inoue, S., et al. (1983). Trace characterization of the Watasenia luciferin in eye and skin photophores and in liver of Watasenia scintillans. Agric. Biol. Chem. 47 635-636. 

There is weak expression of PPARy in muscle, liver and other tissues, enabling TZDs to support the effects of insulin in these tissues, notably increased glucose uptake in muscle and reduced glucose production in liver. TZDs may also affect nutrient metabolism by skeletal muscle through a direct mitochondrial action that is independent of PPARy. 

Tissue expression Mainly white and brown adipose tissue weak expression in liver, muscle, gut, macrophages, pancreatic (3-cells and haemopoietic tissues... 

Hofmann AF (1999) The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 159 2647-2658... 

Primarily hydrolyses esters with longer aliphatic (compared to AChE) or aromatic acyl moiety, such as butyrylcholine (BCh) and benzoylcholine (BzCh). BChE is the primary circulating ChE. It is threefold more abundant than AChE in human blood and is found in liver, lungs, muscles, brain and heart. 

The main mineralocorticoid agonist in humans is aldosterone. Additionally, cortisol, corticosterone, and DOC have also mineralocorticoid agonistic activity. The synthetic steroid fludrocortisone (9a-fluorocorti-sol) is extremely potent and usually chosen for replacement mineralocorticoid therapy. In contrast, aldosterone and DOC are not useful in oral therapy due to rapid degradation in liver after absorption. 

---